Kassandra McFarlane

A cell-free, blood-based DNA screening test for colorectal cancer compared to colonoscopy 1. 83.1% of patients with confirmed colorectal cancer had a positive cfDNA test meeting the accepted standard as outlined by... Mirtazapine improves caloric intake compared to placebo in patients with advanced non-small cell lung cancer 1. While perceived appetite did not differ between study groups, patients receiving mirtazapine had significantly increased caloric consumption compared with... Adenocarcinoma is the most prevalent lung cancer subtype and has a greater incidence rate in males than females 1. The second greatest burden of lung cancer worldwide is attributed to squamous cell carcinoma 2. Large cell carcinoma represents... Atezolizumab is a potentially effective treatment option for patients with alveolar soft part sarcoma 1. 37% of study patients had an objective response to treatment with atezolizumab. 2. Median progression-free survival was 20.8 months....

64%

The Daily's Verdict

This author has a mixed reputation for journalistic standards. It is advisable to fact-check, scrutinize for bias, and check for conflicts of interest before relying on the author's reporting.

Bias

85%

Examples:

  • The author implies that the new blood test is superior to colonoscopy without providing evidence.
  • The author uses biased language such as 'potentially increase screening adherence rates' and 'reduce of CRC-related morbidity and mortality'.

Conflicts of Interest

50%

Examples:

Contradictions

85%

Examples:

  • , Of patients without colorectal cancer, the majority (89.6%) tested negative in the screening blood test.
  • The new home blood test for colorectal cancer is as accurate as current home tests using stool samples.

Deceptions

50%

Examples:

  • The author claims that a blood-based DNA screening test for colorectal cancer has been shown to be as effective as colonoscopy. However, this claim is not supported by the evidence presented in the article.

Recent Articles

Colorectal Cancer Detection: SHIELD Blood Test vs. Colonoscopy Procedure

Colorectal Cancer Detection: SHIELD Blood Test vs. Colonoscopy Procedure

Broke On: Tuesday, 19 March 2024 Colorectal cancer (CRC) can be detected with 80% accuracy using SHIELD, a simple blood test that picks up signs of CRC from DNA shed by tumors. However, it may not detect precancerous lesions and should only be used after consulting with a healthcare professional.